Revolution Medicines Files 8-K

Ticker: RVMD · Form: 8-K · Filed: Apr 13, 2026

Sentiment: neutral

Topics: 8-k, regulatory-filing

TL;DR

REVOLUTION MEDICINES FILED AN 8-K ON 4/13/26 - NO SPECIFIC DETAILS YET.

AI Summary

Revolution Medicines, Inc. filed an 8-K on April 13, 2026, to report other events. The filing does not contain specific financial figures or new material agreements, but serves as a notification of events relevant to the company.

Why It Matters

This filing indicates that Revolution Medicines has had events to report to the SEC, which could be significant for investors monitoring the company's progress and regulatory compliance.

Risk Assessment

Risk Level: low — The filing is a standard 8-K for 'Other Events' and does not disclose specific material financial information or significant corporate actions that would immediately impact risk.

Key Players & Entities

FAQ

What specific 'Other Events' are being reported by Revolution Medicines, Inc. in this 8-K filing?

The provided filing details do not specify the nature of the 'Other Events' beyond the general classification under Item 8.01.

When was this 8-K filing accepted by the SEC?

The 8-K filing was accepted by the SEC on April 13, 2026, at 08:25:24.

What is the CIK number for Revolution Medicines, Inc.?

The CIK number for Revolution Medicines, Inc. is 0001628171.

What is the primary business of Revolution Medicines, Inc. according to the SIC code?

According to the SIC code (2836), Revolution Medicines, Inc. is involved in Biological Products, (No Diagnostic Substances).

Where is Revolution Medicines, Inc. located?

Revolution Medicines, Inc. has its mailing and business address at 700 SAGINAW DR REDWOOD CITY CA 94063.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on April 13, 2026 regarding Revolution Medicines, Inc. (RVMD).

View full filing on EDGAR

View on Read The Filing